Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HIP1801
- Development stage
- Unknown
- Lead developer
- Hanmi Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
HIP1801 is a modified-release, once-daily oral formulation of tamsulosin developed by Hanmi Pharmaceutical for the treatment of benign prostatic hyperplasia (BPH). Tamsulosin is a selective alpha-1 adrenergic receptor antagonist that targets the alpha-1A, alpha-1B, and alpha-1D subtypes. By inhibiting these receptors in the smooth muscle of the prostate and bladder neck, the drug facilitates muscle relaxation, thereby improving urinary flow and alleviating the lower urinary tract symptoms (LUTS) associated with BPH. HIP1801 was designed to optimize the pharmacokinetic profile of tamsulosin, and it has been evaluated in Phase 1 clinical trials comparing its safety and bioavailability to standard tamsulosin capsule formulations (such as HIP1402) under both fasted and fed conditions.
- Other names
- tamsulosin once-dailytamsulosin OD
02
Targets
ADRA1A (α1A)ADRA1B (α1B)ADRA1D (α1D)
Beyond the preview
Go deeper on HIP1801.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HIP1801.